AstraZeneca announced that its U.S. business will publicly share additional or enhanced clinical trials more visible on its Web site. The company stated that "this important information will help the public better understand significant aspects of our business."
To see more Daily News articles, click here.
To go to the Drug Topics homepage, clickhere.
